CC chemokine receptor 4 modulates Toll-like receptor 9-mediated innate immunity and signaling

被引:26
作者
Ishii, Makoto [1 ]
Hogaboam, Cory M. [1 ]
Joshi, Amrita [1 ]
Ito, Toshihiro [1 ]
Fong, Daniel J. [1 ]
Kunkel, Steven L. [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Program Immunol, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
chemokines; macrophages; Toll-like receptors;
D O I
10.1002/eji.200838360
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The present study addressed the modulatory role of CC chemokine receptor 4 (CCR4) in Toll-like receptor (TLR) 9-mediated innate immunity and explored the underlying molecular mechanisms. our results demonstrated that CCR4-deficient mice were resistant to both septic peritonitis induced by cecal ligation and puncture (CLP) and CpG DNA/D-galactosamine-induced shock. in bone marrow-derived macrophages (BMM Phi) from CLP-treated CCR4-deficient mice, TLR9-mediated pathways of MAPK/AP-1, PI3K/Akt, and I kappa B kinase (1KK)/NF-kappa B were impaired compared to wild-type (WT) cells. While TLR9 expression was not altered, the intensity of internalized CpG DNA was increased in CCR4-deficient macrophages when compared to WT macrophages. Pharmacological inhibitor studies revealed that impaired activation of JNK, PI3K/Akt, and/or IKK/NF-kappa B could be responsible for decreased proinflammatory cytokine expression in CCR4-deficient macrophages. interestingly, the CCR4-deficient BMM Phi exhibited an alternatively activated (M2) phenotype and the impaired TLR9-mediated signal transduction responses in CCR4-deficient cells were similar to the signaling responses observed in WT BMM Phi skewed to an alternatively activated phenotype. These results indicate that macrophages deficient in CCR4 impart a regulatory influence on TLR9-mediated innate immunity.
引用
收藏
页码:2290 / 2302
页数:13
相关论文
共 50 条
[1]   Alterations in cell signaling in sepsis [J].
Abraham, E .
CLINICAL INFECTIOUS DISEASES, 2005, 41 :S459-S464
[2]   RGS proteins have a signalling complex: Interactions between RGS proteins and GPCRs, effectors, and auxiliary proteins [J].
Abramow-Newerly, M ;
Roy, AA ;
Nunn, C ;
Chidiac, P .
CELLULAR SIGNALLING, 2006, 18 (05) :579-591
[3]   Pathogen recognition and innate immunity [J].
Akira, S ;
Uematsu, S ;
Takeuchi, O .
CELL, 2006, 124 (04) :783-801
[4]   Expression and function of Toll-like receptor 9 in severely injured patients prone to sepsis [J].
Baiyee, E. E. ;
Flohe, S. ;
Lendemans, S. ;
Bauer, S. ;
Mueller, N. ;
Kreuzfelder, E. ;
Grosse-Wilde, H. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 145 (03) :456-462
[5]  
BAKER CC, 1983, SURGERY, V94, P331
[6]   The role of the Th2CC chemokine ligand CCL17 in pulmonary fibrosis [J].
Belperio, JA ;
Dy, M ;
Murray, L ;
Burdick, MD ;
Xue, YY ;
Strieter, RM ;
Keane, MP .
JOURNAL OF IMMUNOLOGY, 2004, 173 (07) :4692-4698
[7]  
Bernardini G, 1998, EUR J IMMUNOL, V28, P582, DOI 10.1002/(SICI)1521-4141(199802)28:02<582::AID-IMMU582>3.0.CO
[8]  
2-A
[9]   Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice? [J].
Boehlen, F ;
Clemetson, KJ .
TRANSFUSION MEDICINE, 2001, 11 (06) :403-417
[10]   Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s [J].
Bonecchi, R ;
Bianchi, G ;
Bordignon, PP ;
D'Ambrosio, D ;
Lang, R ;
Borsatti, A ;
Sozzani, S ;
Allavena, P ;
Gray, PA ;
Mantovani, A ;
Sinigaglia, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (01) :129-134